Teva Pharmaceutical Industries Ltd (ADR) Sees Unusually High Options Volume (TEVA)
Teva Pharmaceutical Industries Ltd (ADR) (NASDAQ:TEVA) saw some unusual options trading activity on Tuesday. Traders bought 5,406 put options on the company, Analyst Ratings News reports. This is an increase of approximately 112% compared to the typical volume of 2,551 put options.
Several analysts have recently commented on the stock. Analysts at Jefferies Group reiterated a “buy” rating on shares of Teva Pharmaceutical Industries Ltd (ADR) in a research note on Thursday, May 8th. They now have a $61.00 price target on the stock. Separately, analysts at RBC Capital raised their price target on shares of Teva Pharmaceutical Industries Ltd (ADR) from $52.00 to $57.00 in a research note on Friday, May 2nd. Finally, analysts at Maxim Group initiated coverage on shares of Teva Pharmaceutical Industries Ltd (ADR) in a research note on Wednesday, April 30th. They set a “hold” rating and a $49.00 price target on the stock. Nine investment analysts have rated the stock with a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company. The stock currently has an average rating of “Buy” and an average target price of $55.96.
Shares of Teva Pharmaceutical Industries Ltd (NASDAQ:TEVA) traded up 2.42% on Tuesday, hitting $51.20. 4,501,392 shares of the company’s stock traded hands. Teva Pharmaceutical Industries Ltd has a 1-year low of $36.26 and a 1-year high of $54.70. The stock’s 50-day moving average is $50.52 and its 200-day moving average is $44.80. The company has a market cap of $43.556 billion and a price-to-earnings ratio of 30.88.
Teva Pharmaceutical Industries Ltd (ADR) (NASDAQ:TEVA) last released its earnings data on Thursday, May 1st. The company reported $1.22 earnings per share (EPS) for the quarter, meeting the consensus estimate of $1.22. The company had revenue of $5.00 billion for the quarter, compared to the consensus estimate of $5.11 million. During the same quarter in the previous year, the company posted $1.12 earnings per share. The company’s revenue for the quarter was up 2.0% on a year-over-year basis. Analysts expect that Teva Pharmaceutical Industries Ltd will post $4.72 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Monday, June 2nd. Stockholders of record on Tuesday, May 20th will be given a dividend of $0.347 per share. This represents a $1.39 dividend on an annualized basis and a yield of 2.71%. The ex-dividend date of this dividend is Friday, May 16th.
Teva Pharmaceutical Industries Ltd (NASDAQ:TEVA) is an Israel-based pharmaceutical and drug company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.